Describing developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes vaccines and monoclonal antibodies. It discusses targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications.

Contributions by: Rima Menassa, Karen McDonald, Shawn Chen, Inga Hitzeroth, Gregory Pogue, Pascal Drake, Andreas Günter Lössl, M A D'Aoust, David Aviezer, Elizabeth Loza Rubio, John Howard, Carla Marusic, Somen Nandi